AMERICAN CENTURY COMPANIES INC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,769,000
-72.9%
67,071
+3.4%
0.00%
-75.0%
Q3 2021$6,525,000
-28.9%
64,858
+0.0%
0.00%
-33.3%
Q2 2021$9,177,000
+173.5%
64,838
+92.7%
0.01%
+200.0%
Q1 2021$3,355,000
-21.0%
33,653
-2.1%
0.00%
-33.3%
Q4 2020$4,248,000
+27.1%
34,365
+0.1%
0.00%0.0%
Q3 2020$3,343,000
-37.1%
34,316
+0.7%
0.00%
-40.0%
Q2 2020$5,318,000
+44.3%
34,085
+33.5%
0.01%
+25.0%
Q1 2020$3,685,000
-42.0%
25,527
-17.9%
0.00%
-33.3%
Q4 2019$6,356,000
+169.2%
31,091
+5.7%
0.01%
+200.0%
Q3 2019$2,361,000
-21.6%
29,403
-7.9%
0.00%
-33.3%
Q2 2019$3,011,000
+10.1%
31,909
-0.3%
0.00%0.0%
Q1 2019$2,735,000
+18.6%
31,996
-22.2%
0.00%0.0%
Q4 2018$2,307,000
-6.3%
41,124
+36.5%
0.00%
+50.0%
Q3 2018$2,463,00030,1240.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders